Navigation Links
Fifth U.S. Hand Transplant Patient Heads Home to NY

LOUISVILLE, Ky., Feb. 17 /PRNewswire-USNewswire/ -- The United States' fifth hand transplant recipient, Jan "Erik" Hondusky, is heading back home to Massena, New York this week after a three-month stay in Louisville under the care of Kleinert Kutz and University of Louisville surgeons.


Kleinert Kutz and UofL hand surgeons performed the Hondusky's hand transplant at Louisville's Jewish Hospital Hand Care Center on November 24, 2008, during a record nine-hour surgical procedure. Warren C. Breidenbach, M.D., with Kleinert Kutz and University of Louisville assistant clinical professor of surgery, led the team of five hand surgeons, 10 hand fellows and a two-member anesthesiology team from Hand Care Center Anesthesia.

"I cannot wait to get home and pick up my granddaughter with two hands and give big two-handed hugs to all my family and friends, said Hondusky. "This has been an awesome event in my life and I have made many new friends here in Louisville. I cannot thank everyone enough -- the doctors, nurses, therapists, donor family and others who have helped me here in Louisville."

The New York resident is a 43-year-old production worker who injured his dominant right hand in a furnace accident on April 12, 2006, when his hand was crushed and burned thus requiring amputation. He used a prosthetic hand to perform daily living activities before the transplant procedure.

Lead hand transplant surgeon Dr. Breidenbach said, "Erik continues to work on mobility exercises and strengthening the muscle groups in the hand and arm using light weights. Functional activities for grasping, releasing and pinching continue to improve, as well. He can perform such daily living activities as washing his hair with both hands, holding a phone with his new right hand, shaking hands in greeting, opening a door, writing with a pen, grasping a water bottle, throwing and bouncing a ball, and picking up objects three inches wide. He can lift a bucket weighing 12 pounds with his right hand and a 20 pound crate with two hands." Hondusky will continue therapy three times week after returning home.

Kadiyala Ravindra, M.D., University of Louisville assistant professor of surgery, who manages the anti-rejection drug therapy for Hondusky said, "Erik has had a few mild rejection episodes over the past three months, which were not surprising, and we were able to treat each with medication. He is doing remarkably well and we expect him to continue to do so."

Hondusky received one dose of Campath, an immunosuppressive medication, during surgery and is on mono-therapy -- one drug for most of the past three months. Maintaining a patient on one drug as opposed to two or three, reduces the risk of rejection. Risks associated with immunosuppressive drugs include a higher incidence of cancer, infections and other disorders.

"Reducing the number of drugs a patient is on will continue to reduce the risks associated with hand transplantation and we believe we can achieve this with our patients going forward," said Ravindra. "We will also continue to monitor him very closely for signs of rejection with biopsies and other laboratory tests."

A hand transplant, unlike a solid organ transplant, involves multiple tissues (skin, muscle, tendon, bone, cartilage, fat, nerves and blood vessels) and is called composite tissue allotransplantation.

A partnership of physicians and researchers at Jewish Hospital Hand Care Center, Kleinert Kutz and the University of Louisville developed the pioneering procedure. Breidenbach and his team are the only surgeons to perform hand transplants in the U.S. To date, there have been a total of 40 hands transplanted on 32 patients around the world.

Kentuckiana Organ Donor Affiliates (KODA) worked very closely with the Indiana Organ Procurement Organization to coordinate the hand donation with the family and hospital. Without the help of these organ procurement agencies and the family, this procedure could not have taken place.

The fifth U.S. hand transplant is sponsored by the Department of Defense, Office of Naval Research and Office of Army Research to further research in the composite tissue allotransplantation program.

Information, photography and video are available on our web sites at and Video on the website is not broadcast quality.

SOURCE Jewish Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center
2. Dominos Pizza Pledges Support to the Fifth Annual St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign
3. Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
4. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
5. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
6. Cleveland Clinic Surgeons Perform Nations First Near-Total Face Transplant
7. Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients
8. Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
9. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
10. American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant
11. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
Breaking Medicine News(10 mins):